Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. - Wikidata - awgldk - TriplyDB

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.

http://www.wikidata.org/entity/Q34305083

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Importance of Apolipoprotein A-I in Multiple Sclerosis Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Circulating biomarkers that predict incident dementia.Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells.The potential applications of Apolipoprotein E in personalized medicine Developing novel blood-based biomarkers for Alzheimer's disease HDL and cognition in neurodegenerative disorders.Quantitative proteomics of delirium cerebrospinal fluid.Investigating the genetics of hippocampal volume in older adults without dementia.Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms.Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults.Blood protein predictors of brain amyloid for enrichment in clinical trials?Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases The human secretome atlas initiative: implications in health and disease conditions.Age-dependent effect of Alzheimer's risk variant of CLU on EEG alpha rhythm in non-demented adults.Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies.Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases.Is intraindividual reaction time variability an independent cognitive predictor of mortality in old age? Findings from the Sydney Memory and Ageing Study.Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia.Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.Syphilitic dementia and lipid metabolism.Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.Cerebrospinal Fluid Apolipoprotein E Levels in Delirium.Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes.Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.

P2860

Q26774743-16E10295-0437-4607-8489-348A15164A3F Q26774792-0FC98A3F-6EED-4705-B2E3-A0CAB3462C3F Q33637672-4C0A42D4-6322-4B03-8919-BCF495B22B1A Q33752058-473E66EA-EDB3-45FE-9612-66F8A13822EE Q33828385-B48EEB5B-D05F-42B3-8A4E-5342C5E56F13 Q33858831-764DC505-A587-4C2E-878E-4A3134A32276 Q34394080-FB58DB7C-E5CA-4C47-9F8F-8916C2DE5E5B Q34614842-8B7F46BA-404F-489F-9A29-9BE18CF54676 Q34657974-DFF8F72B-1D6B-4E2B-83E2-D40257A8D6C4 Q35019172-D7C22A22-33C3-46B8-813F-6B8EDB0606A8 Q35071184-374CF740-EDB2-4223-B628-434C3CC7509D Q35099780-D5823EC8-C49E-45D0-9C17-7FC7ED47B500 Q36165011-7957CFF2-88F9-4238-8B83-5F6423AAE573 Q36256076-8DEA584E-3AE2-4FFB-BA21-A4B3291E389C Q36349870-3156E710-A3AA-4AC4-85F8-2A6D69AEC1BC Q36409186-0658E971-1F4C-426A-8E61-3D0449357FF8 Q36748126-D715EBA9-9B98-4ABE-9959-BD3BBA74AFE5 Q36926754-5DCDEB22-D8B1-4EC3-98F1-3FF2FF8395CA Q37105427-93A53814-24F4-42C6-ADA5-2C19FF77AB01 Q37105606-A9F56CCD-EB37-4DA0-BE27-F21CECBFFED1 Q37126245-4F6A1817-03BC-4A96-9643-33F9E4BB03A0 Q37389105-16B1CD51-024B-4D4B-8B58-0131D432CD22 Q37504001-37AB5EC6-A4E3-428B-B0CF-58D6359E1C37 Q37559815-F331268E-996B-4D23-80B1-89A40C75073F Q37615967-A7166F94-51CA-4163-98A7-F8F157492C5B Q38287482-2C68E980-47D5-4933-B104-CB92569F0B9E Q38403381-3BEB8C6E-AB10-444E-8121-5AE13CA00BEC Q38632264-2D945A87-DF00-4BEA-BEAB-6061633DB337 Q39230272-4D954D5D-BF4E-4F43-A5E2-06FAC0854342 Q39272772-555E5C20-8149-4F32-A874-7F8878B79FE1 Q39307470-6E9889AD-274E-413A-B400-842B98E02996 Q40401981-4DC53C23-1866-45B5-8BDE-A1698E3FE896 Q40514964-C9602087-D1E7-48DC-95FB-FC0F199964C8 Q40613739-2544C975-71BD-481B-813F-473EFD968F3C Q40825010-851F64E1-AD9B-46CD-A133-BB34576CFE17 Q41488020-76001B2A-3CE0-46D1-ACC7-8F8318A04A78 Q42281478-6424AA73-7BFE-4AF2-8DC5-239DF98E3EA2 Q42328283-7281E719-612E-4712-BDFF-D4A7C134CA9B Q45754969-B14850A3-2F84-4E72-8197-9D87AFC5E988 Q47155881-C983903A-996A-44AC-ACA2-C882ABD0BDA6

P2860

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.

http://www.wikidata.org/entity/Q34305083

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@ast

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@en

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@nl

type

label

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@ast

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@en

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@nl

prefLabel

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@ast

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@en

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@nl

P1433

Q34305083-75AB6476-1425-4C25-806F-F3F63B462F71

P1476

Q34305083-7D1519FB-C711-4E4F-9646-54D3412C6245

P2093

Q34305083-2A68616E-D53A-48B6-8694-CC0DFF869C19

Q34305083-507979E1-732E-49E1-8126-B3A291370123

Q34305083-62BFACF7-4BF0-4460-A4EF-21C933553F9F

Q34305083-744878DA-F4EC-4464-92DA-054A63D9C6BE

Q34305083-7BFAE797-66F0-4CA0-ABF8-BFBE78F9E68C

Q34305083-BD0A0F78-8CD9-4CE3-82BB-D407AD894850

Q34305083-BEBBFAAA-D980-47C7-A89A-2A4D2E52C11B

Q34305083-CFD6716D-2B9E-43EA-BC4D-B3E1DC04DDF1

Q34305083-E96B5187-A1A8-4B85-9F0A-B24C46F419EF

P2860

Q34305083-06F81D4A-9DDA-4BFD-BEDF-F9D44341F4AF

Q34305083-07FC3902-13F3-4816-B698-8238BD0606B4

Q34305083-0B38D7EC-688D-4797-B8B6-B0D2E05A2089

Q34305083-0D84C78E-FC9D-4A6A-B5EC-CCF63172F194

Q34305083-0EDFA530-ACFD-498A-B864-E2CD069232B4

Q34305083-150079C0-ACC9-4093-990D-D4FC3B0F3683

Q34305083-17FDB0B1-C741-4A25-B190-7E93BAFE16DE

Q34305083-1E2BB2B1-09A9-4A41-8252-26306C873906

Q34305083-1F0676F1-A32D-45F6-9AEB-1EF988519F2B

Q34305083-236883B9-16D9-45BA-B383-CFA76B14D9E3

P304

Q34305083-B2EB3374-1908-4E6A-A54F-EEE7D8712A9B

P31

Q34305083-6934791B-D3D7-4ED0-BB05-29D0A8CCE777

P356

Q34305083-0D5FCD2D-5B90-47AA-899D-B31643C7C07C

P407

Q34305083-E9AB64E9-D34A-4973-BCDD-48B52326CCCF

P433

Q34305083-33D4F035-9B8D-4F38-9597-BAB6585564E6

P478

Q34305083-B8C01344-59BF-4073-AF71-F49054BCEACF

P50

Q34305083-0F52752B-A3DD-4DFB-AEF2-DA37128BCCA9

Q34305083-455AA26A-8DB3-4ACB-997F-1BA0C5514BC1

P577

Q34305083-5C034F2C-6EC9-4256-908A-B0E1A84C744A

P5875

Q34305083-A3A24074-7C85-4ECA-9F3A-1A08E54FFEE8

P698

Q34305083-08B4AB42-EC84-4B06-B8A3-F563A0EFD3B7

P932

Q34305083-A0F6B6A5-D1EF-4B77-AD62-ACB1B30D37F4

P356

JOURNAL.PONE.0034078

P1433

P1476

Plasma apolipoprotein levels a ...... y cohort of older individuals.

@en

P2093

Anne Poljak

http://www.w3.org/2001/XMLSchema#string

Barbara Cameron

http://www.w3.org/2001/XMLSchema#string

Fei Song

http://www.w3.org/2001/XMLSchema#string

George A Smythe

http://www.w3.org/2001/XMLSchema#string

John Crawford

http://www.w3.org/2001/XMLSchema#string

Karen Mather

http://www.w3.org/2001/XMLSchema#string

Nicole A Kochan

http://www.w3.org/2001/XMLSchema#string

Ora Lux

http://www.w3.org/2001/XMLSchema#string

Wei Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

“Mini-mental state”

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Mild cognitive impairment as a diagnostic entity

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

P304

e34078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0034078

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Perminder Sachdev

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225376655

http://www.w3.org/2001/XMLSchema#string

P698

22701550

http://www.w3.org/2001/XMLSchema#string

P932

3372509

http://www.w3.org/2001/XMLSchema#string